Can I claim eczema relief or diaper rash treatment on baby products in the U.S.?

Quick Answer (for busy buyers)

Here’s the buyer-first summary. If your brand name is on the label, you usually act as the responsible person and must ensure the listing is submitted and kept current.

• For baby products in the U.S., claims related to eczema relief or diaper rash treatment typically fall under drug regulations enforced by the FDA, meaning they require pre-market approval.
• Cosmetic claims are allowed without approval, but therapeutic claims trigger drug classification, necessitating clinical evidence and FDA submission.
• As an OEM/ODM factory, we guide you through formulation development, such as using gentle, hypoallergenic ingredients, and support stability testing to ensure product safety.
• However, we cannot guarantee regulatory approval; you must consult a legal expert or the FDA for claim substantiation.
• In production, MOQs start at 5,000 units per SKU, with sampling taking 4-6 weeks for formula and packaging compatibility checks.
• Lead time to market is 12-16 weeks after approval, including microbial testing and documentation for customs.
• We provide compliant labeling templates, but you handle claim verification and any required drug applications.